Physician profile
Amit B Varma
NPI 1811180292
$5,739.38
in general payments reported to CMS, 2019-2025
26 companies · $1,946 in 2025
The $1,946 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,372 · 2020: $732 · 2021: $792 · 2022: $190 · 2023: $134 · 2024: $573 · 2025: $1,946.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,618 · Travel and Lodging: $1,035.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,618.08 |
| Travel and Lodging | $1,035.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,183.57 | 2019-2025 | |
| Reel Surgical, INC. | $903.78 | 2020-2025 | |
| Zimmer Biomet Holdings, INC. | $551.81 | 2019-2021 | |
| Innovation Technologies INC | $182.96 | 2022-2023 | Irrisept |
| Bioventus LLC | $154.18 | 2019-2025 | Durolane, Xcell |
| Stryker Corporation | $147.26 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $125.95 | 2024-2025 | |
| Smith+Nephew, INC. | $108.55 | 2021-2025 | Bone Anchors With Arthroscopic Delivery System |
| Vericel Corporation | $49.99 | 2021-2022 | |
| Acumed LLC | $48.11 | 2025 | Acumed, Innate Implant |
| Pacira Therapeutics, INC. | $32.42 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $24.96 | 2025 | Exparel |
| Sanara Medtech INC. | $23.81 | 2022 | |
| Abbott Laboratories | $21.05 | 2021 | |
| Horizon Therapeutics Plc | $20.00 | 2020 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $19.98 | 2025 | Restrata Wound Matrix |
| Endo USA, INC. | $19.46 | 2025 | Xiaflex |
| Depuy Synthes Sales INC. | $18.33 | 2022 | |
| Guard Medical INC. | $16.91 | 2025 | Npseal |
| Ermi LLC | $16.17 | 2019 | |
| Fidia Pharma USA INC. | $15.96 | 2025 | Hymovis, Triluron |
| Ethicon US, LLC | $13.55 | 2022 | |
| Zyla Life Sciences, INC. | $13.05 | 2019 | |
| Heraeus Medical, LLC. | $12.74 | 2025 | |
| Embody, INC. | $10.94 | 2022 | |
| Heron Therapeutics, INC. | $3.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Varma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.